Dopamine-β-hydroxylase and norepinephrine in human cerebrospinal fluid: Effects of monoamine oxidase inhibitors
- 1 April 1979
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 18 (4), 423-426
- https://doi.org/10.1016/0028-3908(79)90152-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Dopamine‐ß‐hydroxylase activity in human cerebrospinal fluid and serumJournal of Neurochemistry, 1977
- Lack of correlation of plasma norepinephrine and dopamine-beta-hydroxylase in hypertensive and normotensive subjects.Circulation Research, 1977
- Use of plasma norepinephrine for evaluation of sympathetic neuronal function in manLife Sciences, 1976
- Norepinephrine in cerebrospinal fluidBrain Research, 1976
- Dopamine-β-Hydroxylase Activity in Serum and Cerebrospinal Fluid in Neuropsychiatric DiseasesNeuropsychobiology, 1976
- Dopamine‐β‐hydroxylase activity in human cerebrospinal fluidJournal of Neurochemistry, 1976
- Localization of the noradrenergic nervous system in human brainJournal of Psychiatric Research, 1974
- Effects of reserpine on the content and properties of rat adrenal medullary storage vesiclesBiochemical Pharmacology, 1973
- Serum Dopamine-β-Hydroxylase: Decrease after Chemical SympathectomyScience, 1971
- Release of catecholamines and dopamine-β-oxidase from the adrenal medullaLife Sciences, 1968